Latest Red blood cell Stories
A University of Michigan Health System laboratory study reveals a key trigger for producing normal red blood cells that could lead to a new treatment for those with sickle cell disease.
Professor Qin Wenbin from BaoTou Medical College first identified the hemoglobin (Hb) A2 phenomenon 30 years ago.
Researchers at St. Michael's Hospital have discovered a new function for an enzyme that may protect against organ injury and death from anemia.
Using a patient’s own stem cells, researchers at Johns Hopkins have corrected the genetic alteration that causes sickle cell disease (SCD), a painful, disabling inherited blood disorder that affects mostly African-Americans.
More public awareness and education about sickle cell disease, an inherited disease that affects the blood system, is critically important.
As researchers continue to study the use of hydroxyurea as a treatment for sickle cell disease, there is more evidence to validate that it is safe and effective for children with the disease, said an expert pediatric hematologist from Baylor College of Medicine.
For the first time, researchers have successfully injected cultured red blood cells (cRBCs) created from human hematopoietic stem cells (HSCs) into a human donor.
Recent studies have shown that the heart contains cardiac stem cells that can contribute to regeneration and healing during disease and aging.
- To swell, as grain or wood with water.